Matthew Herman is the Head of U.S. Corporate for Freshfields Bruckhaus Deringer. He spoke with Rhonda Schaffler at The Deal Economy Event and told her "the easy deals have kind of been done."
From an execution perspective, he says the big public takeovers are relatively easy, but things get more difficult when it comes to preparing for carveouts like H.R., operations, and financials.
When it comes to divestiture, Herman says uncertainty can lead to dislocation, but smart buyers can move on that dislocation.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.
Email
Email sent
Thank you, your email to has been sent successfully.